POWAR试验:肾捐献者手辅助腹腔镜供肾切除术前单剂抗生素预防术后感染
POWAR是英国多中心双盲安慰剂对照随机试验,评估术前单剂静脉co-amoxiclav能否降低手辅助腹腔镜供肾切除(HALDN)术后30天感染。293例捐献者随机接受抗生素或生理盐水,抗生素组总感染率23%(34/148),安慰剂组40.7%(59/145),P=0.001。单剂预防使术后感染绝对风险降低17.7%(95%CI 7.2%-28.1%),需治疗6例捐献者预防1例感染。
要点
- 术前单剂co-amoxiclav使HALDN术后30天总感染率从40.7%降至23%。
- 浅表手术部位感染从20.7%降至10.1%,下呼吸道感染从9%降至3.4%。
- 尿路感染两组差异无统计学意义(4.1% vs 3.4%,P=0.72)。
核心结论
- 术前单剂抗生素预防可显著降低HALDN术后感染率,主要影响手术部位感染和下呼吸道感染。
研究设计与样本
- 英国多中心双盲安慰剂对照随机试验,293例合格捐献者随机接受术前单剂静脉co-amoxiclav或生理盐水,99%(291/293)完成随访。
主要发现
- 抗生素组总感染率23%(34/148),安慰剂组40.7%(59/145),P=0.001。
- 浅表手术部位感染抗生素组10.1%(15/148),安慰剂组20.7%(30/145),P=0.012。
- 下呼吸道感染抗生素组3.4%(5/148),安慰剂组9%(13/145),P=0.046。
- 尿路感染抗生素组3.4%(5/148),安慰剂组4.1%(6/145),P=0.72。
- 抗生素预防使术后感染绝对风险降低17.7%(95%CI 7.2%-28.1%),需治疗6例捐献者预防1例感染。
临床怎么用
- 对于接受HALDN的肾捐献者,可考虑术前单剂静脉co-amoxiclav预防术后感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative infection after hand-assisted laparoscopic donor nephrectomy (HALDN) confers significant morbidity to a healthy patient group. Current UK guidelines cite a lack of evidence for routine antibiotic prophylaxis. This trial assessed if a single preoperative antibiotic dose could reduce post HALDN infections. METHODS: Eligible donors were randomly and blindly allocated to preoperative single-dose intravenous co-amoxiclav or saline. The primary composite endpoint was clinical evidence of any postoperative infection at 30 days, including surgical site infection (SSI), urinary tract infection (UTI), and lower respiratory tract infection (LRTI). FINDINGS: In all, 293 participants underwent HALDN (148 antibiotic arm and 145 placebo arm). Among them, 99% (291/293) completed follow-up. The total infection rate was 40.7% (59/145) in the placebo group and 23% (34 of 148) in the antibiotic group (P = 0.001). Superficial SSIs were 20.7% (30/145 patients) in the placebo group versus 10.1% (15/148 patients) in the antibiotic group (P = 0.012). LRTIs were 9% (13/145) in the placebo group and 3.4% (5/148) in the antibiotic group (P = 0.046). UTIs were 4.1% (6/145) in the placebo group and 3.4% (5/148) in the antibiotic group (P = 0.72).Antibiotic prophylaxis conferred a 17.7% (95% confidence interval 7.2%-28.1%), absolute risk reduction in developing postoperative infection, with 6 donors requiring treatment to prevent 1 infection. INTERPRETATION: Single-dose preoperative antibiotic prophylaxis dramatically reduces post-HALDN infection rates, mainly impacting SSIs and LRTIs.
引用
- Ahmed Z, Uwechue R, Chandak P, et al. Prophylaxis of Wound Infections-antibiotics in Renal Donation (POWAR): A UK Multicentre Double Blind Placebo Controlled Randomised Trial. Ann Surg. 2020. PMID: 31714309. doi:10.1097/SLA.0000000000003666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。